Metabolic Activity Dead Cell Apoptosis Kit with C12 Resazurin, Annexin V APC, and SYTOX™ Green, for flow cytometry
Metabolic Activity Dead Cell Apoptosis Kit with C12 Resazurin, Annexin V APC, and SYTOX™ Green, for flow cytometry
Invitrogen™

Metabolic Activity Dead Cell Apoptosis Kit with C12 Resazurin, Annexin V APC, and SYTOX™ Green, for flow cytometry

Ce produit de cytométrie en flux offre un dosage de fluorescence à trois couleurs qui distingue les cellules apoptotiques vivantesAfficher plus
Have Questions?
RéférenceQuantité
V351141 kit
Référence V35114
Prix (EUR)
1 198,00
1 kit
Ajouter au panier
Quantité:
1 kit
Prix (EUR)
1 198,00
1 kit
Ajouter au panier
Ce produit de cytométrie en flux offre un dosage de fluorescence à trois couleurs qui distingue les cellules apoptotiques vivantes et les cellules apoptotiques tardives les unes des autres. Ces populations peuvent être facilement distinguées à l’aide d’un cytomètre en flux qui possède des sources d’excitation de 488 nm et 633 nm (un laser à ions d’argon et un laser HeNe) et les réactifs suivants : annexine V pour détecter la phosphatidylsérine, résazurine C12 pour le métabolisme cellulaire, et colorant d’acide nucléique vert SYTOX™ pour les membranes compromises.

Consultez un guide de sélection pour tous les dosages d’apoptose pour la cytométrie en flux.
Usage exclusivement réservé à la recherche. Ne pas utiliser pour des procédures de diagnostic.
Spécifications
Excitation / émissionRésazurine C12 : 571⁄585, vert SYTOX™ : 503⁄524, APC : 650 / 660
Faisceaux laser du cytomètre en flux633/635, 488
À utiliser avec (application)Cytométrie en flux
À utiliser avec (équipement)Microscope à fluorescence, cytomètre en flux
Nbre de réactions50 reactions
Gamme de produitsSYTOX
Type de produitKit d’apoptose des cellules mortes
Quantité1 kit
Conditions d’expéditionGlace humide
ConjuguéAPC (Allophycocyanine), SYTOX™ Green résazurine C12
FormatTube, lame
Unit Size1 kit
Contenu et stockage
Contient 1 flacon d’annexine V, conjugué APC (250 µl), 1 flacon de coloration verte SYTOX™ (100 µl), 1 flacon de résazurine C12 (40 µg) et 1 flacon de DMSO (1,5 ml).

Conserver au réfrigérateur (2–8°C) et à l’abri de la lumière.

Foire aux questions (FAQ)

How do SYTO dyes bind to DNA?

The binding mode of SYTO nucleic acid stains is unknown. However, the behavior of these and related nucleic acid dyes suggests the following binding properties:

1.They appear to contact the solvent (suggested by sensitivity to salt, divalent cations, and in particular, SDS) and thus are likely to have contacts in the grooves.
2.All SYTO dyes appear to show some base selectivity and are thus likely to have minor groove contacts.
3.They can be removed from nucleic acid via ethanol precipitation; this characteristic is not shared by ethidium bromide and other intercalators. Likewise, the dyes are not removed from nucleic acid via butanol or chloroform extraction. These extraction methods do remove ethidium bromide from nucleic acid. 4. SYTO binding is not affected by nonionic detergents.
5. SYTO dyes are not quenched by BrdU, so they do not bind nucleic acids in precisely the same way as Hoechst 33342 and DAPI ((4′,6-diamidino-2-phenylindole).

SYBR Green I has shown little mutagenicity on frameshift indicator strains, indicating that it isn't likely to strongly intercalate.

Find additional tips, troubleshooting help, and resources within our Cell Analysis Support Center.

I trypsinized my adherent cells and labeled with annexin V, and now my flow data is showing a high percentage of apoptotic cells even for control, untreated cells. What is the problem?

Trypsinization or mechanical scraping of cells temporarily disrupts the plasma membrane, allowing annexin V to bind phosphatidylserine on the cytoplasmic surface of the cell membrane and thus leading to false positive staining. Allow the cells to recover for about 30 minutes in optimal cell culture conditions and medium after trypsinizing/scraping so that they can recover their membrane integrity before staining. For lightly adherent cell lines, such as HeLa and NIH 3T3, another option is to use non-enzyme treatments like Gibco Cell Dissociation Buffer (Cat. No. 13151014).

Find additional tips, troubleshooting help, and resources within our Cell Analysis Support Center.

Can I detect annexin V staining in an imaging assay?

Annexin V staining is not typically used in imaging experiments; it is a better reagent for flow cytometry analysis. All cells will stain to some extent, so it can be difficult to distinguish a relatively bright annexin V-stained cell from a dimmer non-apoptotic cell. Caspase activation, detected using our CellEvent Caspase 3/7 or Image-iT LIVE Caspase detection kits, is a better method for detecting apoptosis in an imaging assay.

Find additional tips, troubleshooting help, and resources within our Cell Analysis Support Center.

When should I stain adherent cells with annexin V for flow cytometric analysis? Before or after I trypsinize them?

Trypsinize first and then allow the cells to recover about 30 minutes in optimal cell culture conditions and medium before staining with annexin V conjugates. Trypsinization or mechanical scraping of cells temporarily disrupts the plasma membrane, allowing for annexin V to bind phosphatidylserine on the cytoplasmic surface of the cell membrane and thus leading to false positive staining. For lightly adherent cell lines such as HeLa and NIH 3T3, you could use a less harsh (non-enzymatic) dissociation product like Gibco Cell Dissociation Buffer (Cat. No. 13151014).

Find additional tips, troubleshooting help, and resources within our Cell Analysis Support Center.

Can I fix my cells after annexin V staining?

Yes, this is possible. We have established protocols for annexin V staining combined with intracellular staining of lymphocytes that can be found here. The most important step is to leave some binding buffer in the suspension when fixation is started. Compared to staining of live cells, the intensity of the annexin V signal may be somewhat reduced.

Citations et références (2)

Citations et références
Abstract
Bruton's tyrosine kinase is at the crossroads of metabolic adaptation in primary malignant human lymphocytes.
Authors:Sharif-Askari B, Doyon D, Paliouras M, Aloyz R
Journal:Sci Rep
PubMed ID:31363127
'In this work we explored metabolic aspects of human primary leukemic lymphocytes that hold a potential impact on the treatment of Bruton tyrosine kinase (BTK)-driven diseases. Our results suggest that there is crosstalk between Bruton tyrosine kinase (BTK) signaling and bioenergetic stress responses. In primary chronic lymphocytic leukemia (CLL) lymphocytes, ... More
Ibrutinib Resistance Is Reduced by an Inhibitor of Fatty Acid Oxidation in Primary CLL Lymphocytes.
Authors:Galicia-Vázquez G, Aloyz R
Journal:Front Oncol
PubMed ID:30319974
Chronic Lymphocytic Leukemia (CLL) is an incurable disease, characterized by the accumulation of malignant B-lymphocytes in the blood stream (quiescent state) and homing tissues (where they can proliferate). In CLL, the targeting of B-cell receptor signaling through a Burton's tyrosine kinase inhibitor (ibrutinib) has rendered outstanding clinical results. However, complete ... More